Type 1 ryanodine receptor-based methods
US7312044B2 · kind B2 · utility
6Cited by
123References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Dec 25, 2007 |
| Priority date | — |
| Expiry date | Mar 5, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/99
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods of treating defective skeletal muscle function during heart failure and methods for identifying compounds useful in such treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.